EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Eudragit-Based Nanoparticles for Oral Drug Delivery

Filipa Bettencourt, Patrícia C Pires iD, Francisco Veiga, Ana Cláudia Paiva-Santos iD, Amélia C F Vieira iD

Pharmaceutics · 30.06.2026 · 18 (7) · 813

DOI: 10.3390/pharmaceutics18070813 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.06.2026. Verfasst von Filipa Bettencourt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Pólo das Ciências da Saúde, Azinhag…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was financed by National Funds through FCT/MCTES-Portuguese Foundation for Science and Technology within the scope of the project UIDB/50006/2025-htt…, National Funds through FCT/MCTES—Portuguese Foundation for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of oral drug delivery systems has become a major priority for pharmaceutical technology, driven by the growing demand for medicinal products that improve compliance, enhance therapeutic efficacy, and minimise drug-related adverse effects. Therefore, the ability to modulate drug release kinetics through systems capable of controlled and targeted delivery is crucial. In this context, Eudragit-based nanoparticles have demonstrated great potential in enhancing drug stability, controlling release profiles, and improving site-specific targeting in the gastrointestinal tract. Polymethacrylate copolymers (Eudragit®) exhibit pH-dependent solubility, mucoadhesive properties, and tunable drug-loading capacities, making them highly suitable for advanced oral formulations. This review provides a comprehensive analysis of the use of Eudragit® in the design of nanoparticulate systems for oral drug delivery: inorganic nanoparticles, nanocrystals, lipid-based carriers, and polymeric nanoparticles. A special focus is given to the formulation’s composition, preparation method, physicochemical properties and the mechanisms of controlled drug release, but also to in vitro, ex vivo, and in vivo characterisation. Emphasis is placed on controlled-release strategies, targeted delivery, and the impact of polymeric materials in optimising therapeutic outcomes. By exploring these aspects, this review aims to highlight current research advances on Eudragit-based nanoparticles, their potential applications, and the challenges that must be addressed before these nanosystems can be considered robust platforms for improving oral drug bioavailability and efficacy.

Schlagwörter

Stichwörter der Autor:innen

Eudragitcontrolled drug releasenanoparticlesoral drug deliverypolymethacrylate

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
  • LAQV/REQUIMTE, Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
  • Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.
  • Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.
  • RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.

ORCID-Profile: Patrícia C Pires, Ana Cláudia Paiva-Santos, Amélia C F Vieira

Förderung

  • This work was financed by National Funds through FCT/MCTES-Portuguese Foundation for Science and Technology within the scope of the project UIDB/50006/2025-htt…
  • National Funds through FCT/MCTES—Portuguese Foundation for Science and Technology

Zitieren

APA

Bettencourt, F., Pires, P. C., Veiga, F., Paiva-Santos, A. C., & Vieira, A. C. F. (2026). Eudragit-Based Nanoparticles for Oral Drug Delivery. Pharmaceutics, 18(7), 813. https://doi.org/10.3390/pharmaceutics18070813

Vancouver

Bettencourt F, Pires PC, Veiga F, Paiva-Santos AC, Vieira ACF. Eudragit-Based Nanoparticles for Oral Drug Delivery. Pharmaceutics. 2026;18(7):813. doi:10.3390/pharmaceutics18070813

BibTeX
@article{Bettencourt2026,
  author = {Bettencourt, Filipa and Pires, Patrícia C and Veiga, Francisco and Paiva-Santos, Ana Cláudia and Vieira, Amélia C F},
  title = {Eudragit-Based Nanoparticles for Oral Drug Delivery},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {813},
  doi = {10.3390/pharmaceutics18070813}
}
Kostenlos starten →